Ill patient, public activist: Rose Kushner's attack on breast cancer chemotherapy.
In 1984 the noted breast cancer activist Rose Kushner published a controversial article, "Is Aggressive Adjuvant Chemotherapy the Halsted Radical of the '80s?" In it, she argued that chemotherapy was being used as indiscriminately as the radical mastectomy had been, before she and others had successfully discredited the disfiguring operation. As with all of Kushner's writings, this article raised valid points in an informed and provocative style, but her attack on chemotherapy was more one-sided than was typical. This may have been due to the highly personal nature of the topic: when she was diagnosed with recurrent breast cancer, she had declined chemotherapy in favor of a hormonal agent, tamoxifen. She also developed a close working and financial relationship with the manufacturers of tamoxifen. Although not seen as a problem at the time, Kushner's dual roles as patient and advocate for a particular treatment foreshadowed conflict-of-interest issues that would take center stage in medicine in subsequent decades.
Lerner
Barron H
BH
Columbia College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. BHL5@columbia.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000266:history; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000266:history*; D016265:Conflict of Interest; D015195:Drug Design; D004345:Drug Industry; D004992:Ethics, Medical; D005197:Famous Persons; D005260:Female; D049673:History, 20th Century; D006801:Humans; D010344:Patient Advocacy / Q000266:history*; D011057:Politics